Binding to the EGFR triggers intracellular signaling events through at least three major pathways (the AKT, MAPK, and STAT pathways), leading to proliferation, invasion, angiogenesis, metastasis, and inhibition of apoptosis (uncontrolled tumor growth) [5,6]. The gene discussed is EGFR; the disease is neoplasm.